AKT1 and melanoma: To summarize, our studies demonstrate that miR-30a-5p could influence cisplatin-resistance by targeting IGF1R gene and AKT/P53 pathway in melanoma cells, which might provide a potential target for the therapy of chemo-resistant melanoma cells.